| scholarly article | Q13442814 |
| P50 | author | James C Johnston | Q91197185 |
| Dick Menzies | Q30004466 | ||
| P2093 | author name string | Federica Fregonese | |
| Olivia Oxlade | |||
| Jonathon R Campbell | |||
| Kamila Romanowski | |||
| P2860 | cites work | Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults | Q24201466 |
| Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis | Q28477855 | ||
| Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients | Q28482730 | ||
| Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal | Q28548604 | ||
| Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis. | Q52623025 | ||
| Rapid molecular detection of tuberculosis and rifampin resistance | Q29617127 | ||
| The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis | Q30235074 | ||
| Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance | Q33595994 | ||
| Isoniazid-resistant tuberculosis: a cause for concern? | Q33820505 | ||
| Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review | Q33869390 | ||
| Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994-2009 | Q33988089 | ||
| The clinical decision analysis using decision tree | Q34608270 | ||
| Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. | Q36386227 | ||
| Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis | Q39014367 | ||
| Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis. | Q39094119 | ||
| Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial | Q39520488 | ||
| Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis | Q40043590 | ||
| Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis? | Q41849725 | ||
| Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries | Q44528463 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tuberculosis | Q12204 |
| multiple drug resistance | Q643839 | ||
| isoniazid | Q423169 | ||
| P304 | page(s) | e0211355 | |
| P577 | publication date | 2019-01-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study | |
| P478 | volume | 14 |
Search more.